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Comparative activity of the penem antibiotic Sch 34343 against
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to multiresistant strains
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Institute of Medical Microbiology, University of Zurich, 8028 Zurich, Switzerland
A new penem antibiotic, Sch 34343, was shown to be active against a large number
of Gram-positive bacteria. The drug inhibited peniciUinase-positive and -negative
staphylococci equally well, being five times more active than cefamandole and
ten times more active than methiallin. Most methicillin-resistant staphy-
lococci were inhibited by concentrations between 0-25 and 4 mg/1, but a small
group of highly resistant strains were observed. Sch 34343 was eight times less
active than ampicillin and penicillin G, but as active as piperacilhn against
enterococci. The drug showed excellent activity against various streptococci.
Sch 34343 was as bactericidal as flucloxacilhn, ampicillin and penicillin G against
staphylococci, enterococci and streptococci, respectively, in lulling kinetic tests
Enterobacteriaceae susceptible to third-generation cephalosporins were
approximately five times less susceptible to Sch 34343, but MICs were far below the
susceptibility breakpoint Sch 34343 was equally active against Citrobacter and
Enterobacter strains that were highly resistant to third-generation cephalosporins
and to aztreonam. Together with thienamycin, this drug seems to be a good
alternative for the treatment of infections caused by bacteria resistant to third-
generation cephalosporins and to aztreonam.
Introduction
Sch 34343 is a new penem antibiotic which is chemically related to the carbapenem
antibiotic thienamycin. This study was undertaken to compare the in-vitro efficacy of
Sch 34343 with various other /Mactam antibiotics. Some 250 clinical isolates of Gram-
positive organisms were included in the study to provide a good indication of the
potential efficacy of the drug in the therapy of Gram-positive infections. Special
emphasis was given to the bactericidal activity of the drug against Gram-positive
bacteria. The activity of Sch 34343 was also examined against Enterobacteriaceae
including a small collection of multiply-resistant organisms, which were resistant to the
third-generation cephalosporins, aztreonam and often also to aminoglycosides.
Methods
Bacteria
The bacteria used were isolated from clinical material and identified according to
standard procedures. Two hundred and sixty eight Gram-positive organisms were
examined. The collection of Gram-negative bacilli comprised Escherichia coli (24),
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Klebsiella pneumoniae (21), K. oxytoca (10), K. ozaenae (4), Enterobacter cloacae (29),
Ent. aerogenes (13), Ent. agglomerans (11), Citrobacter freundii (50), Citro. diversus (6),
Citrobacter spp. (5), Serratia marcescens (16), Ser. liquefaciens (6), Proteus mirabilis
(17), iV. vulgaris (22), Morganella morganii (4), Providentia rettgeri (7), and
/Vov. stuartii (6). Strains susceptible to third-generation cephalosporins were fresh
clinical isolates. Strains resistant to cephalosporins were derived from worldwide
sources.
Antibiotics
Stock solutions of Sch 34343, imipenem, penicillin G, ampicillin, piperacillin, oxacillin,
fiucloxacillin, methicillin, cephalothin, cefamandole, cefotaxime, ceftriaxone,
cefoperazone, ceftazidime, latamoxef (moxalactam), and aztreonam were prepared in
sterile distilled water and either used immediately or stored at — 80°C, if necessary. All
drugs were provided by the pharmaceutical companies.
Minimal inhibitory concentration tests
Minimal inhibitory concentrations (MICs) were determined by serial two-fold
dilutions of antibiotics, usually in Mueller-Hinton agar (BBL) or broth. Pneumococci
and haemolytic streptococci were tested on agar containing 1% (w/v) IsoVitaleX
(BBL) and 1% (w/v) haemoglobin (BBL). The inoculum in agar dilution was about
10* per spot, and in macro-broth dilution 5 x 105 to 106 per ml. MICs were read after
incubation at 35°C for 18-24 h. The MIC techniques corresponded to the procedures
proposed by the National Committee of Clinical Laboratory Standards (1983).
Bactericidal tests
The concentrations that killed 99% and 99-9% of the inoculum were determined by
plating 100 and 10 /A of the broth from each tube of the macro dilution test showing
no growth on blood agar. Before plating, 200 y\ of an enzyme solution containing
approximately 8 (if concentrations of drugs were < 10mg/l) or 80 (if concentrations
were >10mg/l) units of penicillin amido-/?-lactamhydrolase E.C. 3.5.2.6. from
Bacillus cereus 569/H9 (Genzyme Biochemicals Ltd., Springfield Mill, Maidstone) per
ml were added to the broth tubes and incubated at room temperature for 5 min. This
served to destroy any drug and, thus, to avoid carry-over of bacteriostatic activity.
Kinetics of killing was investigated in 20 ml of Mueller-Hinton broth,
unsupplemented or supplemented with IsoVitaleX and haemoglobin (see above) when
necessary. Four times the MIC of the various drugs were added. At appropriate time
intervals, samples were withdrawn, incubated with the B. cereus enzyme as described
and plated undiluted or in appropriate dilutions.
Population analysis
Populations of methicillin-resistant staphylococci were analysed by disaggregation
of overnight broth cultures (briefly, by ultra sonication at 20 kHz) and surface
inoculation of appropriate dilutions on drug-containing Mueller-Hinton agar plates.
Colony counts after 48 h of incubation at 30 or 37°C allowed calculation of the
number of viable units among 108 cfu resistant to each concentration of antimicrobial
agent.
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Table I. Comparative activity of Sch 34343 and other /Mactam antibiotics against Gram-positive
bacteria
Organism
(no. of isolates)
Staph. aureus
perucillinase-negative (13)
Staph. aureus
penicillmase-positive (20)
Staph aureus
methicillin-resistant (39)
Staph epidermidis
penicillinase-negative (14)
Staph. epidermidis
penicillinase-positive (27)
Staph. epidermidis
methicilhn-resistant (14)
Sir faecalis (31)
Drug
Sch 34343
imipenem
penicillin G
methicillin
cefamandole
Sch 34343
imipenem
methicillin
cefamandole
cefotaxime
Sch 34343
Sch 34343 (30°Q
imipenem
methicillin
cefamandole
cefotaxime
Sch 34343
imipenem
penicillin G
methicillin
cefamandole
Sch 34343
imipenem
methicillin
cefamandole
ceftriaxone
Sch 34343
imipenem
ceftriaxone
Sch 34343
imipenem
penicillin G
ampicillin
piperacillin
cefamandole
Mean
Oi l
008
002
1
0-21
015
009
1 68
0-5
22
0-69
1 6
0-23
4-76
1 9
21-2
0-23
007
002
1-77
0-27
013
012
219
0-27
21
5-4
2
176
5-9
2-4
1-9
0-9
5-9
25
Mode
012
012
0 03
1
0-25
012
012
2
0 5
2
1
*
012
003
003
1
0-25
012
001
2
0-25
2
*
+
*
4
2
2
1
4
32
MIC (mg/1)*
Range
0-06-0-25
003-0-12
001-006
0 5-2
012-0-25
006-0-5
003-012
1-2
0-25-2
2-4
0 12-256
0-5-256
006-128
1-256
0-25-256
8-256
0-06-1
0-03-1
0-01-0 12
0-5-8
0-06-1
006-0-25
001-0-25
0-5-16
0-06-2
0-25-16
1-128
0 06-32
4-256
4-32
\-4
1-2
0-5-2
1-8
16-32
MIC50»
012
006
0 01
0-5
012
012
006
1
1
2
0-5
1
0 12
4
1
32
0 25
006
001
1
0 12
0 12
006
1
012
2
4
2
8
4
2
1
05
4
16
MIC 9 0 '
012
012
001
1
0-25
0-25
012
2
2
2
4
4
1
8
4
64
0-5
0 25
006
4
0 5
0 25
0-25
4
0 5
8
8
16
128
8
4
2
1
8
32
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Table I. (continued)
Organism
(no. of isolates)
Str.faecium (14)
Sir. pyogenes (18)
Str. agalactiae (9)
Str. pneumoniae (28)
Corynebacterium JK (12)
Corynebacterium
unspecified (34)
Drug
Sch 34343
imjpenem
penicillin G
ampicillin
piperacillin
cefamandole
Sch 34343
imipenem
penicillin g
cefamandole
ceftriaxone
Sch 34343
imipenem
penicillin G
cefamandole
ceftriaxone
Sch 34343
imipenem
penicillin G
cefamandole
ceftriaxone
Sch 34343
imipenem
Sch 34343
imipenem
Mean
32
6-9
3-4
0-4
13-8
74
006
005
001
005
003
015
0-42
0 03
0 13
0 25
007
011
001
003
003
369
362
6-7
2-4
Mode
*
•
•
*
*
*
006
003
001
006
003
012
0-5
003
012
0-25
006
006
001
006
003
256
256
*
•
MIC (mg/1)*
Range
4-256
003-64
0-25-16
05-16
1-64
2-256
003-012
003-012
001
001-012
003
012-0-25
0-25-0-5
003
003-012
0-25
0-03-0-5
003-0-5
001-003
001-0-25
001-0-25
128-256
128-256
003-256
003-256
MIC50»
32
8
2
2
16
64
006
003
001
003
003
012
0-5
0 03
006
0-25
006
006
001
003
003
256
256
1
0-25
MICV
128
32
16
8
32
256
006
012
001
012
003
0-25
0-5
0 03
0-25
0-25
0-25
0-25
001
012
003
256
256
256
256
' Data obtained with the agar dilution procedure of the National Committee of Clinical Laboratory
Standards (1983). Incubation was carried out at 35°C, unless otherwise indicated, for 18-24 h
* Concentration required to inhibit 50 or 90% of the examined strains, respectively
* Wide range of MICs
Results
Comparison of Sch 34343 with other fi-lactam antibiotics against Gram-positive bacteria
Table I summarizes MICs of Sch 34343 and other drugs against Gram-positive
bacteria. As can be seen, the drug showed excellent activity against staphylococci,
whether they produced penicillinase or not. The drug was 15 times more active than
methicillin and exhibited two to four times better activity than cefamandole against
methicillin-susceptible cultures. Imipenem was either two to four times more active or
showed equal activity to Sch 34343. Imipenem and Sch 34343 also showed some
activity against methicillin-resistant Staph. aureus and Staph. epidermidis, when tested
in agar dilution with an inoculum of 10* per spot and incubated for 24 h at 35°C.
Incubation of plates for 48 h or incubation at 30°C increased MICs by a factor of
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Figure 1. Composition of highly methialLn-rcsistant Staph aureus strain EK 695 of cells with different
levels of resistance to Sch 34343, imipenem, cefamandole and oxacillin
5-10. These two drugs were slightly more active than cefamandole, which was shown
elsewhere to be one of the most active /Mactam drugs against methicillin-resistant
staphylococci (Kayser, 1980).
Heterogeneity amongst the methicillin-resistant staphylococci was observed with
Sch 34343. The drug was more active than cefamandole and oxacillin and of similar
activity to imipenem in these population studies (Figure 1).
Although Sch 34343 was not as potent as penicillin or ampicillin against the
enterococci, it showed some activity, equal to that of piperacillin, and ten times or
more the activity of the cephalosporins. Imipenem also proved to have moderate
activity against enterococci.
Sch 34343 and imipenem were equally active against various species of streptococci.
However, penicillin G still remained the most potent agent against these organisms.
Although corynebacteria are generally contaminants in microbiological samples,
group JK cornynebacterium has been associated with severe infections, particularly in
immunosuppressed patients (Young et al., 1981). The organism has also been isolated
occasionally from cases of peritonitis in patients undergoing continuous ambulatory
peritoneal dialysis (Pierard et al., 1983). These organisms have been found to be
resistant to many antimicrobials including the aminoglycosides and /Mactam
antibiotics. JK cornynebacteria were also found to be highly resistant to Sch 34343
and to imipenem. Other unspecified corynebacteria, which were isolated from
infectious lesions and, thus, might have played a role in disease, exhibited strain-
dependent susceptibility or resistance to both drugs.
Bactericidal activity of Sch 34343
Examination of the bactericidal activity of Sch 34343 and comparative agents was
carried out in conventional MBC tests (Anhalt, Sabath & Barry, 1980) in triplicate
Although great care was taken in performing these tests, results were often
inconsistent, due to multiple methodological problems (Taylor et al., 1983; Kayser &
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Table II. Bactericidal activity of Sch 34343 in comparison with penicillin G, ampicillin and
flucloxacillin against Gram-positive bacteria
Organism
Staph. aweus 41
penicillinase-positive
Staph. aweus 61
penicillinase-negative
Staph. epidermidis 145
penicillinase-positive
Staph. epidermidis 162
penicillinase-negative
Str. faecalis 97
Str.faecium 128
Str. pyogenes 193
Str agalactiae 219
Str. pneumoniae 241
Str. mutans 349
MIC (mg/ir
Sch Comparative
34343
012
006
006
012
8
16
012
012
001
006
drug1
0-25
0-25
0-25
0-5
1
2
003
006
003
003
MBC99 (mg/1)*
Sch Comparative
34343
2
0 25
1
1
64
> 6 4
1
1
003
0-25
drug*
0-25
0 25
1
1
32
> 6 4
003
0-25
001
> 6 4
MBG,
Sch
34343
> 6 4
> 6 4
32
1
> 6 4
> 6 4
> 6 4
1
0 03
> 6 4
wOng/06
Comparative
drug'
> 6 4
0-25
4
16
> 6 4
> 6 4
0-25
0-5
0 01
> 6 4
' Minimal inhibitory concentration determined in macro-broth dilution according to the NCCLS
procedure.
* Concentration necessary to kill 99 or 99 9% of the inoculum, respectively.
' Comparative drug for staphylococa was flucloxacillin, for enterococci ampicillin and for streptococci
penicillin G.
Mtiller, 1983). Table II summarizes some of the results obtained. With the exception of
enterococci, Sch 34343 showed good bactericidal activity at the 99% killing level. At
the 99-9% level, however, it was often not bactericidal even at high concentrations.
Sometimes the comparative agent also was not bactericidal at this level. Sometimes
Sch 34343 was active, but the comparative drug was not. No paradoxical effect (Eagle
&. Musselman, 1948) was observed with strains and drugs examined. We therefore
decided to study the bactericidal potential of Sch 34343 in a kinetic system. Figure 2
shows that Sch 34343 extensively killed the organisms examined with a rate identical to
that of the comparative drugs.
Comparison of Sch 34343 with other fi-lactam antibiotics against Gram-negative bacteria
Recent reports have shown that Enterobacteriaceae can become resistant to third-
generation cephalosporins by mutation in a chromosomal locus, regulating the
production of a cephalosporinase (Seeberg, Tolxdorff-Neutzling & Wiedemann, 1983).
The frequency of resistant mutants of this type in clinical isolates is still low (Kayser
& Kohler, 1984). They have mainly been observed in Citrobacter and Enterobacter
species. We collected such strains from our area and from worldwide sources and
examined the activity of Sch 34343 against them. Table III summarizes the results
obtained. For comparative purposes, data about the activity of the advanced /Mactam
antibiotics against strains of Enterobacteriaceae susceptible to third-generation
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Control
Staph. oureus
(pencillinoie- poictive)
o I
o 9
E
z
Stoph oureus
(pentcillinase -negotive)
Sch 34343 (4«MIC)
Flucloxacillcn (4 x MIC)
j I I i
( c )
24 2
T i m e ( h )
24
Figure 2. Rates of lulling of Staph. aureui, Sir. faecalis, Str. pyogenes and Sir. pneumomae by Sch 34343
(O O) and fluclocaallin (A A), ampicillin (A A) and penicillin G (A A),
respectively (a) Open symbols: Staph aureus 41 (peniallinase-positive) MIC of Sch 34343 = 0 125 and of
flucloxacillin =• 0-25 mg/1 Closed symbols Staph. aureus 61 (perucillinase negative). MIC of
Sch 34343 = 0 06 and flucloxaallin = 0 25 mg/1 (b) Str faecalis 97 MIC of Sch 34343 - 8 and of
ampicillin = 1 mg/1. (c) Sir. pyogenes 193 MIC of Sch 34343 = 0125 and of penicillin G = 0-03 mg/1 (</)
Str pneumomae 241. MIC of Sch 34343 = 0-008 and of penicillin G = 003 mg/1
cephalosporins have been included. It can be seen that Sch 34343 was not as active as
third-generation cephalosporins and aztrenonam on a weight basis against susceptible
organisms. MICs of Sch 34343, however, were in a range easily obtained in tissue by
normal dosing (Investigational Brochure, Schering Corp., Kenilworth, NJ). However,
Sch 34343 and imipenem were only slightly less active against organisms highly
resistant to third-generation cephalosporins and to aztreonam, than against the
susceptible group.
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Table HI. Comparison of Sch 34343 with other /Mactam antibiotics against Gram-negative
bacteria susceptible or resistant to third-generation cephalosponns
Organism'
(no. of isolates)
E. coli
no. sensitive (24)
Klebsiella spp.
no. sensitive (34)
no. resistant (1)
Enterobacter spp.
no. sensitive (27)
no. resistant (26)
Serratut spp.
no. sensitive (21)
no resistant (1)
Citrobacter spp.
no. sensitive (43)
no. resistant (18)
Drug
Sch 34343
imipenem
cefotaxime
cefoperazone
ceftriaxone
ceftazidime
latamoxef
aztreonam
Sch 34343
imipenem
cefotaxime
cefoperazone
ceftriaxone
ceftazidime
latamoxef
aztreonam
Sch 34343
imipenem
cefotaxime
cefoperazone
ceftriaxone
ceftazidime
latamoxef
aztreonam
Sch 34343
imipenem
cefotaxime
cefoperazone
ceftriaxone
ceftazidime
latamoxef
aztreonam
Sch 34343
imipenem
cefotaxime
cefoperazone
ceftriaxone
ceftazidime
latamoxef
aztreonam
1vflCs (mg/1) of
susceptible
Mean
0 6
0-2
01
1-7
01
0-3
0 2
0-2
0-3
0-2
01
4-7
0-3
0-4
0-3
0 6
0-7
0-4
0-2
0-3
0-2
0-6
0-3
0-2
1-8
0-4
0-4
8-8
0-3
0-3
0-6
0-3
0-5
0-3
0-2
11
01
0-45
0-2
0-2
Mode
1
012
012
•
012
012
0-25
012
0-25
0-25
006
*
006
0-25
006
006
0-5
0-25
*
0-25
012
0-25
012
012
2
0-25
0-25
16
012
006
0-25
012
0-5
0-25
012
0-25
006
0-25
012
006
isolates
Range
012-16
0 06-1
0 03-2
0-12-64
003-0-25
0-03-2
0-06-0-25
0-03-1
0-12-1
0-12-1
0 01-2
012-256
0-03-64
0-06-2
0-03-2
0-03-64
012^4
0-06-^
0-01-8
001-16
0-01-16
0-06-64
0-06-32
0 03-16
0-5-16
0-25-4
0-06-8
0-5-64
0-03-8
0-06-16
006-256
0-06-4
012-2
0 12-1
001-8
006-32
0-01-16
006-16
0-06-8
003-32
Mean
1
0-5
16
16
16
16
16
4
2-1
0-4
85-6
36-5
730
50-2
9-9
26-5
16
1
16
16
4
16
256
2
0-8
0-3
38-5
47-2
40-2
38-8
3-7
13 2
MICs (mg/1) of
resistant isolates
Mode
1
0-5
128
32
128
64
8
*
1
0-25
32
32
32
*
*
*
Range
0-5-16
012-2
16-> 256
2-> 256
8->256
4->256
1-128
1-256
0-25-4
0-12-1
16-128
16->256
16-256
006- > 256
0 12-64
0-25-> 256
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Organism"
(no. of isolates)
Pr. mirabilis
no. sensitive (17)
Pr. vulgaris
Morg. morganii
Providencia spp.
no. sensitive (39)
Drug
Sch 34343
imipencm
cefotaxime
cefoperazone
ceftriaxone
ceftazidime
laLamoxef
aztreonam
Sch 34343
imipenem
cefotaxime
cefoperazone
ceftriaxone
ceftazidiroe
latamoxef
aztreonam
MICs (mg/1) of
susceptible
Mean
0-9
0-7
002
0-4
001
004
01
002
0-8
0-6
002
0-6
002
005
0-4
004
Mode
0-5
0-5
001
0-25
001
003
012
001
0-5
1
001
0-5
001
003
0-25
001
isolates
Range
0-25-2
006-4
001-006
012-8
001
001-O-5
006-0-25
001-003
0-5-4
0-03-4
0-01-0-25
0-06-8
001-0-25
0-01-2
0-03-0-5
OOl^t
M I Q (mg/1) of
resistant isolates
Mean Mode Range
' Number of isolates susceptible (MIC
• Wide range of MICs.
8 mg/1) or resistant (MIC > 8 mg/1) to cefotaxime.
Discussion
Sch 34343 has been shown in this study to be an excellent antibiotic against most
species of Gram-positive bacteria. In particular, it exhibited some activity against
methicillin-resistant staphylococci, although the typical characteristics of these
bacteria—heterogeneity and influence of incubation temperature on phenotypic
expression of resistance—were also observed with Sch 34343. The drug was only three
to four times less active than imipenem against methicillin-resistant staphylococci in
agar dilution tests, but the numbers of sub-populations resistant to each drug were the
same (see Figure 1). These two drugs, therefore, could be considered as a possible
choice in the treatment of infections caused by such bacteria in exceptional cases, if for
instance other antimicrobials such as vancomycin, could not be used. The general rule,
however, that infections by methicillin-resistant staphylococci should not be treated
with any /?-lactam agent, is valid for Sch 34343 and imipenem. Sch 34343 exhibited
high activity against streptococci and pneumococci, but enterococci were not as
susceptible as towards penicillin G or ampicillin. Against Streptococcus faecalis,
however, the drug was as active as piperacillin.
Sch 34343 was as bactericidal as comparative agents (flucloxacillin, ampicillin and
penicillin (G) against representative Gram-positive bacteria in the kinetic studies. The
variable results obtained with Sch 34343 and the comparative drugs in conventional
MBC 99-9% tests reflect the laboratory problems connected with this procedure
(Taylor et al., 1983; Kayser & Muller, 1983).
Although Sch 34343 was approximately five times less active than third-generation
cephalosporins against Enterobacteriaceae, MICs were far below the susceptibility
146 F. H. Kayser et al.
threshold. MICs were not (or only by one dilution) elevated against Citrobacter and
Enterobacter strains, highly resistant to third-generation cephalosporins. This
behaviour reflects the extreme stability of the drug to /Mactamases, since it has been
shown that cephalosporin resistance in such strains is due to chromosomal
cephalosporinase (Sanders & Sanders 1983, Seeberg et al., 1983). Sch 34343, thus,
together with imipenem, can be considered as potent chemotherapeutic agents in
infections caused by Enterobacteriaceae resistant to third-generation cephalosporins
and to aztreonam.
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